Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
07 mai 2024 13h52 HE
|
Invizyne Technologies, Inc.
Michael Heltzen appointed as CEO bringing 20 years of global commercial leadership experience and a track record of successful launches and exits Additional industry veterans join in...
Invizyne Technologies Announces Filing of Registration Statement for Proposed Offering and Listing on Nasdaq
12 févr. 2024 08h00 HE
|
Invizyne Technologies, Inc.
Monrovia, CA, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC,...
Michael Burns Joins Invizyne as Executive Vice President of Energy Transition
08 nov. 2023 16h05 HE
|
Invizyne Technologies, Inc.
Monrovia, CA, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC,...
Invizyne Selected by Shell GameChanger Accelerator Powered by NREL for Sixth Cohort
17 oct. 2023 10h00 HE
|
Invizyne Technologies, Inc.
Monrovia, CA, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB Capital Holdings, LLC,...
Invizyne Awarded Additional $3.77 Million Grant from U.S. Department of Energy
11 oct. 2023 11h10 HE
|
Invizyne Technologies, Inc.
Monrovia, CA, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of enzyme-based biomanufacturing systems – and a “Big Idea” company from MDB Capital Holdings, LLC,...